Update from BioCryst Pharmaceuticals regarding intravenous peramivir (News-Medical-Net)
September 30, 2009 — JesseBioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S.
More here:
Update from BioCryst Pharmaceuticals regarding intravenous peramivir (News-Medical-Net)